|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 46, 2636-2648, December 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology


* Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec H9H 3L1, Canada
Published, JLR Papers in Press, October 3, 2005. DOI 10.1194/jlr.M500213-JLR200
1 To whom correspondence should be addressed. e-mail: treawouns{at}aol.com
The mammary gland, like most tissues, produces measurable amounts of prostaglandin E2 (PGE2), a metabolite of arachidonic acid produced by sequential actions of two cyclooxygenases (COX-1 and COX-2) and three terminal PGE synthases: microsomal prostaglandin E2 synthase-1 (mPGES1), mPGES2, and cytosolic prostaglandin E2 synthase (cPGES). High PGE2 levels and COX-2 overexpression are frequently detected in mammary tumors and cell lines. However, less is known about PGE2 metabolic enzymes in the context of normal mammary development. Additionally, the primary COX partnerships of terminal PGE synthases and their contribution to normal mammary PGE2 biosynthesis are poorly understood. We demonstrate that expression of COX-1, generally considered constitutive, increases dramatically with lactogenic differentiation of the murine mammary gland. Concordantly, total PGE2 levels increase throughout mammary development, with highest levels measured in lactating tissue and breast milk. In contrast, COX-2 expression is extremely low, with only a modest increase detected during mammary involution. Expression of the Gs-coupled PGE2 receptors, EP2 and EP4, is also temporally regulated, with highest levels detected at stages of maximal proliferation. PGE2 production is dependent on COX-1, as PGE2 levels are nearly undetectable in COX-1-deficient mammary glands. Interestingly, PGE2 levels are similarly reduced in lactating glands of mPGES1-deficient mice, indicating that PGE2 biosynthesis results from the coordinated activity of COX-1 and mPGES1.
We thus provide evidence for the first time of functional coupling between COX-1 and mPGES1 in the murine mammary gland in vivo.
Abbreviations: AA, arachidonic acid; COX, cyclooxygenase; cPGES, cytosolic prostaglandin E2 synthase; LC-MS, liquid chromatography-mass spectrometry; mPGES, microsomal prostaglandin E2 synthase; PGDH, NAD+-dependent 15-hydroxyprostaglandin dehydrogenase; PGE2, prostaglandin E2; PGH2, prostaglandin endoperoxide; PR, progesterone receptor; TXB2, thromboxane B2; VEGF, vascular endothelial growth factor
Supplementary key words prostanoid eicosanoid metabolism gene regulation prostaglandin E2 receptors EP2 EP4 mouse mammary development microsomal prostaglandin E2 synthase-1 cytosolic prostaglandin E2 synthase cyclooxygenase-1
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. L. Barclay, S. T. Anderson, M. J. Waters, and J. D. Curlewis Characterization of the SOCS3 Promoter Response to Prostaglandin E2 in T47D Cells Mol. Endocrinol., October 1, 2007; 21(10): 2516 - 2528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Ledford, M. Kovarova, and B. H. Koller Impaired Host Defense in Mice Lacking ONZIN J. Immunol., April 15, 2007; 178(8): 5132 - 5143. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |